Method for in vitro diagnosis or prognosis of colon cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 27, 2022
Grant Date -
Nov 27, 2014
app pub date -
Dec 17, 2012
filing date -
Dec 20, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present invention relates to a method for in vitro diagnosis or prognosis of colon cancer, including a step of detecting at least one expression product of at least one HERV nucleic acid sequence, the use of said isolated nucleic acid sequences as a molecular marker/molecular markers, and a kit including at least one specific binding partner for at least one expression product of the HERV nucleic acid sequences.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2012 Application Filing Year
- C12Q Class
- 2418 Applications Filed
- 1732 Patents Issued To-Date
- 71.63 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C12Q Class
- 0 % this patent is cited more than
- 3 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Mar 27, 2026 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Mar 27, 2030 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Mar 27, 2034 |
